Nurse Practitioner, Family · Albany, NY
NPI
1609176361
Since 2010
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
43 New Scotland Ave
Albany, NY, 12208
Phone (518) 264-5053
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
121 services
Medicare patients, 2024
30
Average age 50
Drug cost, 2024
$196K
519 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel R Resnick was code 99214 (office e&m - established), 49 times for 13 patients. In total Daniel R Resnick billed 121 services in 15 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 49 | 13 | $83.42 | $4,088 |
By year: 2023 $6,322 for 133 services; 2024 $13K for 121 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel R Resnick prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 279 prescriptions and refills. In total Daniel R Resnick wrote 519 Medicare prescriptions that cost $196K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 279 | 279 | 53 | $53K |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 48 | 48 | Under 11 | $36K |
| Zubsolv Buprenorphine Hcl/Naloxone Hcl | 42 | 42 | Under 11 | $40K |
| Buprenorphine Hcl Generic | 41 | 41 | Under 11 | $2,375 |
| Sublocade Buprenorphine | 26 | 26 | Under 11 | $51K |
| Belbuca Buprenorphine Hcl | 17 | 17 | Under 11 | $11K |
Brand drugs: - claims; generic drugs: 379 claims; opioid claims: 18.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Daniel R Resnick were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.